Neuromodulation to Facilitate the Effect of Ketamine

Ketamine

Brief Summary

application of external neuromodulation along with ketamine infusion.

Intervention / Treatment

  • co-administration of TMS and infused ketamine (OTHER)

Condition or Disease

  • Depression
  • Chronic Pain
  • Substance Abuse

Phase

Study Design

Study type: OBSERVATIONAL
Status: Completed
Study results: No Results Available
Age: 18 Years and older   (Adult, Older Adult)
Enrollment: 35 (ACTUAL)
Funded by: Other
Time Perspective: Retrospective
Observational Model: Case-Control

Masking

Clinical Trial Dates

Start date: Jan 01, 2011
Primary Completion: Nov 01, 2012 ACTUAL
Completion Date: Nov 01, 2012 ACTUAL
Study First Posted: Mar 22, 2013 ESTIMATED
Results First Posted: Aug 31, 2020
Last Updated: Mar 20, 2013

Sponsors / Collaborators

Lead Sponsor: The Neuroscience Center, LLC
Lead sponsor is responsible party
Responsible Party: N/A

Location

Deerfield, Illinois, USA

apply TMS concurrent with ketamine infusion in order to increase the likliehood \& strength of therapeutic benefit

Participant Groups

  • co-administration of TMS and infused ketamine for patients with chronic pain of psyche and/or soma

Eligibility Criteria

Sex: All
Minimum Age: 18
Age Groups: Adult / Older Adult
Healthy Volunteers: Yes

Inclusion Criteria:

* chronically ill,
* treatment-resistant

Exclusion Criteria:

* active psychosis

Primary Outcomes

  • treat in order to cause remission of disability

More Details

NCT Number: NCT01816958
Acronym: TMS/ketamine
Other IDs: 12_1293
Study URL: https://clinicaltrials.gov/study/NCT01816958
Last updated: Sep 29, 2023